Industry

Serotiny Announces a Research Collaboration With Janssen to Optimize Designs for Chimeric Antigen Receptors Signaling Domains

The collaboration will utilize the Serotiny platform to design, analyze, evaluate, and screen Multi-Domain Protein libraries aiming to identify novel Chimeric Antigen Receptors (CAR) signaling domains SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Serotiny, a leader in high-throughput therapeutic Multi-Domain Protein (tMDP) engineering, announced today a collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of … [Read more…]

GSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and older

PRIORIX becomes an additional source of measles, mumps and rubella vaccine for US patients PHILADELPHIA–(BUSINESS WIRE)–#GSK–GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved PRIORIX (Measles, Mumps and Rubella Vaccine, Live) for active immunisation for the prevention of measles, mumps and rubella (MMR) in individuals 12 months of … [Read more…]

Vertex Presents New Data from VX-880 Phase 1/2 Clinical Trial at the American Diabetes Association 82nd Scientific Sessions

– Patient 1 showed blood glucose time-in-range change from 40.1% on 34.0 units per day of exogenous insulin at baseline to 99.9% and insulin independence at Day 270 – – Patient 2 showed blood glucose time-in-range change from 35.9% on 25.9 units per day of exogenous insulin at baseline to 51.9% with a 30% reduction … [Read more…]

Global Healthy Living Foundation Study Reports that Nearly Half of Formulary Exclusions Have Questionable Health and Financial Benefits for Patients

Secret Negotiations by PBMs Prioritize Profits Over Patient Outcomes UPPER NYACK, N.Y.–(BUSINESS WIRE)–#PBM–A peer reviewed paper published in Health Science Journal from the Global Healthy Living Foundation evaluating the 2022 national formulary of the second-largest PBM in the US found that nearly half (46%) of their 563 exclusions had questionable clinical or financial benefits to … [Read more…]

Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, presented results from the Phase II SUMMIT trial, assessing the efficacy of combined neratinib, fulvestrant, and trastuzumab in patients with hormone receptor positive, HER2-negative, HER2-mutant metastatic breast cancer, at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held in person from June 3-7 … [Read more…]

LeanTaaS Announces Growth Investment by Bain Capital Private Equity to Fuel Leading AI-Driven Platform for Hospitals to Achieve Operational Excellence

Investment will Enable Company to Scale Leading Cloud Software Suite for Intelligent Operations SANTA CLARA, Calif.–(BUSINESS WIRE)–LeanTaaS Holdings, Inc. (the “Company”), a leading provider of cloud software solutions for optimizing hospital operations and capacity management, today announced that Bain Capital Private Equity (“Bain Capital”) has acquired a majority stake in the Company from existing investors … [Read more…]

The WellSky® Foundation Grants $100,000 to the American Heart Association® to Provide STEM Scholarships and Educational Opportunities

American Heart Association’s STEM Goes Red initiative gains resources to provide STEM-focused programs and mentorship for young women in the Kansas City area OVERLAND PARK, Kan.–(BUSINESS WIRE)–Today the WellSky Foundation, a nonprofit dedicated to improving quality of life for vulnerable populations, announced it has made donations totaling $100,000 to the American Heart Association® STEM Goes … [Read more…]

Soleo Health Named to Genentech’s Limited Drug Distribution Network for Provision of ENSPRYNG®

Company to Distribute FDA-Approved Treatment for Neuromyelitis Optica Spectrum Disorder FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare—Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been named a limited distribution drug partner for ENSPRYNG® (satralizumab-mwge), manufactured by Genentech, a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines … [Read more…]

Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities

EMERYVILLE, Calif. & ALBANY, N.Y.–(BUSINESS WIRE)–#AMRI–Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Curia, formerly AMRI, a leading contract research, development and manufacturing organization (CDMO), today announced Curia’s adoption of The Beacon® Optofluidic system and workflows from Berkeley Lights to accelerate and expand its antibody-based drug discovery capabilities. The Beacon system … [Read more…]

AnHeart Therapeutics and Innovent Biologics Present Updated Phase 2 Efficacy and Safety Data of Taletrectinib (ROS1 Inhibitor) at ASCO 2022

In 67 ROS1 TKI-naïve patients, the confirmed objective response rate (cORR) and disease control rate (DCR) were 92.5% and 95.5%, respectively. In 38 crizotinib-pretreated patients, the cORR and DCR were 50% and 78.9%, respectively. In 12 patients with brain metastasis and measurable brain lesions at baseline, the intracranial cORR and intracranial DCR were 91.7% and … [Read more…]